Antimicrobial profiles of bacterial clinical isolates from the Gabonese National Laboratory of Public Health: Data from routine activity

International Journal of Infectious Diseases

Volumn 29, Issue , 2014, Pages 48-53

  Kouegnigan Rerambiah, Léonard ^a   Ndong, Jean Charles ^a   Mbakob Mengue Massoua, Pauline ^a   Medzegue, Severin ^a   Elisee Ndam, Médard ^a   Mintsa Ndong, Armel ^a   Djoba Siawaya, Joel Fleury ^a  

^a Libreville   (Gabon)

Author keywords

Antimicrobial; Bacteria; Clinical isolates; Resistance

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; OXACILLIN; PENICILLIN G; QUINOLONE DERIVATIVE; TEICOPLANIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GABONESE; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; NONHUMAN; PELVIC EXAMINATION; PUBLIC HEALTH; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SAPROPHYTICUS; STENOTROPHOMONAS; STREPTOCOCCUS; URINE CYTOLOGY; VAGINAL SWAB; BACTERIUM; DIAGNOSTIC PROCEDURE; DRUG EFFECTS; GABON; ISOLATION AND PURIFICATION; LABORATORY;

ANTI-BACTERIAL AGENTS; BACTERIA; CLINICAL LABORATORY TECHNIQUES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GABON; HUMANS; LABORATORIES; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 84910060834     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.01.015     Document Type: Article

References (32)

1. Groome M.J., Albrich W.C., Wadula J., Khoosal M., Madhi S.A. Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance. Paediatr Int Child Health 2012, 32:140-146.
2. Mhada T.V., Fredrick F., Matee M.I., Massawe A. Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome. BMC Public Health 2012, 12:904.
3. Berkley J.A., Lowe B.S., Mwangi I., Williams T., Bauni E., Mwarumba S., et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005, 352:39-47.
4. Howard D., Cordell R., McGowan J.E., Packard R.M., Scott R.D., Solomon S.L. Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention Emory Workshop. Clin Infect Dis 2001, 33:1573-1578.
5. Neidell M.J., Cohen B., Furuya Y., Hill J., Jeon C.Y., Glied S., Larson E.L. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis 2012, 55:807-815.
6. Roberts R.R., Hota B., Ahmad I., Scott 2nd R.D., Foster S.D., Abbasi F., et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009, 15:1175-1184.
7. Okeke I.N., Klugman K.P., Bhutta Z.A., Duse A.G., Jenkins P., O'Brien T.F., et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005, 5:481-493.
8. Fuller J.D., Low D.E. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 2005, 41:118-121.
9. Collignon P., Wegener H.C., Braam P., Butler C.D. The routine use of antibiotics to promote animal growth does little to benefit protein undernutrition in the developing world. Clin Infect Dis 2005, 41:1007-1013.
10. Phillips I., Casewell M., Cox T., De Groot B., Friis C., Jones R., et al. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 2004, 53:28-52.
11. File T.M. The science of selecting antimicrobials for community-acquired pneumonia (CAP). J Manag Care Pharm 2009, 15:S5-S11.
12. Fuller J.D., McGeer A., Low D.E. Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management. Eur J Clin Microbiol Infect Dis 2005, 24:780-788.
13. Watkins R.R., Lemonovich T.L. Diagnosis and management of community-acquired pneumonia in adults. Am Fam Physician 2011, 83:1299-1306.
14. Jean S.S., Teng L.J., Hsueh P.R., Ho S.W., Luh K.T. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital. J Antimicrob Chemother 2002, 49:69-76.
15. Fernandez-Canigia L., Dowzicky M.J. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob 2012, 11:29.
16. Rupp M.E., Fey P.D. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003, 63:353-365.
17. Krucke G.W., Grimes D.E., Grimes R.M., Dang T.D. Antibiotic resistance in Staphylococcus aureus-containing cutaneous abscesses of patients with HIV. Am J Emerg Med 2009, 27:344-347.
18. Oteo J., Campos J., Baquero F., Spanish members of EARSS System. SmotEARS. Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001). J Antimicrob Chemother 2002, 50:945-952.
19. Bourjilat F., Dersi N., Bouchrif B., Amarouch H., Timinouni M. Profil de résistance aux antibiotiques des Escherichia coli uropathogènes communautaires au Maroc. Eur J Sci Res 2009, 38:57-62.
20. Lepelletier D., Caroff N., Reynaud A., Richet H. Escherichia coli: epidemiology and analysis of risk factors for infections caused by resistant strains. Clin Infect Dis 1999, 29:548-552.
21. Sotto A., Merle De Boever C., Fabbro-Peray P., Gouby A., Sirot D., Jourdan J. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study. J Clin Microbiol 2001, 39:438-444.
22. Lau S., Peng M., Chang F. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. J Microbiol Immunol Infect 2004, 37:185-191.
23. Robert J., Cambau E., Grenet K., Trystram D., Péan Y., Fiévet M.H., Jarlier V. Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98. Clin Microbiol Infect 2001, 7:553-561.
24. Kiratisin P., Chongthaleong A., Tan T.Y., Lagamayo E., Roberts S., Garcia J., et al. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study. Int J Antimicrob Agents 2012, 39:311-316.
25. Kiratisin P., Keel R., Nicolau D. Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region. Int J Antimicrob Agents 2013, 41:47-51.
26. Dias R., Louro D., Canica M. Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period. Antimicrob Agents Chemother 2006, 50:2098-2105.
27. Cunha B.A. Clinical relevance of penicillin-resistant Streptococcus pneumoniae. Semin Respir Infect 2002, 17:204-214.
28. Bisno A.L., Gerber M.A., Gwaltney J.M., Kaplan E.L., Schwartz R.H. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002, 35:113-125.
29. Gosbell I.B., Fernandes L.A., Fernandes C.J. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Pathology 2006, 38:343-348.
30. Nys S., Okeke I.N., Kariuki S., Dinant G.J., Driessen C., Stobberingh E.E. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother 2004, 54:952-955.
31. Sun L., Klein E., Laxminarayan R. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis 2012, 55:687-694.
32. Donkor E.S., Tetteh-Quarcoo P.B., Nartey P., Agyeman I.O. Self-medication practices with antibiotics among tertiary level students in Accra, Ghana: a cross-sectional study. Int J Environ Res Public Health 2012, 9:3519-3529.